BeautyHealth reports Q3 net loss of $73.8M, revises FY2023 guidance lower

SkinHealth Systems Inc.

2023-Q3 EPS reported -$0.68 revenue$301,170,000

Net sales $97.4M (+10% YoY) but gross loss of $12.6M vs $61.4M profit a year ago; $63.1M restructuring charge for Syndeo device upgrades.
Net loss $73.8M vs $0.1M loss prior year; adjusted EBITDA $9.1M (9.3% margin) down from $16.3M (18.4% margin).
Revised FY2023 guidance: net sales $385-400M, adjusted EBITDA margin 5-6%; suspends long-term 2025 outlook.
U.S. revenue weaker than expected; APAC and EMEA delivered double-digit growth; total delivery systems sold 2,140 vs 1,860.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SkinHealth Systems Inc. reported third quarter ended September 30, 2023 results: revenue $97.4 million, net income $(73.8). Guidance reaffirmed.

Period: third quarter ended September 30, 2023
Revenue: $97.4 million
Net income: $(73.8)
Guidance: reaffirmed
Result: reported results

Exact text from the filing

revenue and incurs restructuring charges for device upgrades Delivers net sales of $97.4 million driven by double digit growth in APAC and EMEA Long Beach, Calif., November 13, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2023.

View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-038610

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.